Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cancer

INDICATION: Cancer

In vitro and cell culture studies identified a HRAS- and KRAS-binding monobody that could help treat

Read the full 178 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE